Video
17 Jun 2025

Multi-Attribute Method: An Emerging Platform for Product Development

A review of various methods and instrumentation, including the benefits and limitations for each in biomanufacturing. Regulatory views, including description of use/acceptance at each phase of drug discovery from pre-clinical through BLA. Case Study.

Content provided by our supplier

SGS North America Inc.

  • US
  • 2015
    On CPHI since
View company profile

Other Content from SGS North America Inc. (1)

  • Bioanalysis Testing Solutions

    Brochure Bioanalysis Testing Solutions

    With over 30 years of experience and operating out of our GLP/GCP compliant laboratories. SGS has the expertise to both develop assays from scratch (including LC-MS/MS, immunoassays and cell-based assays) and to support large scale routine sample analyses, from regulatory pre-clinical (toxicology) to early and late clinical studies (Phase I to IV).